Brain protection by anesthetic agents

Ines Koerner, Ansgar Brambrink

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Patients at risk for perioperative stroke, or those who have suffered recent cerebral injury, may benefit from neuroprotective properties of anesthetic agents during surgery. This manuscript reviews recent clinical and experimental evidence for neuroprotective effects of common anesthetic agents, and presents potential mechanisms involved in anesthetic neuroprotection. RECENT FINDINGS: Although strong experimental data support a neuroprotective potential of several anesthetic agents, specifically isoflurane and xenon, consistent long-term protection by either agent has not been demonstrated. Unfortunately, there is a lack of clinical studies that would support the use of any one anesthetic agent over the others. Mechanisms of neuroprotection by anesthetic agents appear to involve suppression of excitatory neurotransmission, and potentiation of inhibitory activity, which may contribute to the reduction of excitotoxic injury. Activation of intracellular signaling cascades that lead to altered expression of protective genes may also be involved. SUMMARY: Solid experimental evidence supports neuroprotection by anesthetic agents. It is too early to recommend any specific agent for clinical use as a neuroprotectant, however. Further study is warranted to unravel relevant mechanisms and to appreciate the potential clinical relevance of experimental findings.

Original languageEnglish (US)
Pages (from-to)481-486
Number of pages6
JournalCurrent Opinion in Anaesthesiology
Volume19
Issue number5
DOIs
StatePublished - Oct 2006

Fingerprint

Anesthetics
Brain
Neuroprotective Agents
Xenon
Isoflurane
Wounds and Injuries
Synaptic Transmission
Stroke
Gene Expression
Neuroprotection

Keywords

  • Anesthesia
  • Neuroprotection
  • Neurotoxicity
  • Perioperative cerebral ischemia
  • Posttreatment
  • Preconditioning

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Brain protection by anesthetic agents. / Koerner, Ines; Brambrink, Ansgar.

In: Current Opinion in Anaesthesiology, Vol. 19, No. 5, 10.2006, p. 481-486.

Research output: Contribution to journalArticle

Koerner, Ines ; Brambrink, Ansgar. / Brain protection by anesthetic agents. In: Current Opinion in Anaesthesiology. 2006 ; Vol. 19, No. 5. pp. 481-486.
@article{e348f61fbf234fb0980801191b799ec6,
title = "Brain protection by anesthetic agents",
abstract = "PURPOSE OF REVIEW: Patients at risk for perioperative stroke, or those who have suffered recent cerebral injury, may benefit from neuroprotective properties of anesthetic agents during surgery. This manuscript reviews recent clinical and experimental evidence for neuroprotective effects of common anesthetic agents, and presents potential mechanisms involved in anesthetic neuroprotection. RECENT FINDINGS: Although strong experimental data support a neuroprotective potential of several anesthetic agents, specifically isoflurane and xenon, consistent long-term protection by either agent has not been demonstrated. Unfortunately, there is a lack of clinical studies that would support the use of any one anesthetic agent over the others. Mechanisms of neuroprotection by anesthetic agents appear to involve suppression of excitatory neurotransmission, and potentiation of inhibitory activity, which may contribute to the reduction of excitotoxic injury. Activation of intracellular signaling cascades that lead to altered expression of protective genes may also be involved. SUMMARY: Solid experimental evidence supports neuroprotection by anesthetic agents. It is too early to recommend any specific agent for clinical use as a neuroprotectant, however. Further study is warranted to unravel relevant mechanisms and to appreciate the potential clinical relevance of experimental findings.",
keywords = "Anesthesia, Neuroprotection, Neurotoxicity, Perioperative cerebral ischemia, Posttreatment, Preconditioning",
author = "Ines Koerner and Ansgar Brambrink",
year = "2006",
month = "10",
doi = "10.1097/01.aco.0000245271.84539.4c",
language = "English (US)",
volume = "19",
pages = "481--486",
journal = "Current Opinion in Anaesthesiology",
issn = "0952-7907",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Brain protection by anesthetic agents

AU - Koerner, Ines

AU - Brambrink, Ansgar

PY - 2006/10

Y1 - 2006/10

N2 - PURPOSE OF REVIEW: Patients at risk for perioperative stroke, or those who have suffered recent cerebral injury, may benefit from neuroprotective properties of anesthetic agents during surgery. This manuscript reviews recent clinical and experimental evidence for neuroprotective effects of common anesthetic agents, and presents potential mechanisms involved in anesthetic neuroprotection. RECENT FINDINGS: Although strong experimental data support a neuroprotective potential of several anesthetic agents, specifically isoflurane and xenon, consistent long-term protection by either agent has not been demonstrated. Unfortunately, there is a lack of clinical studies that would support the use of any one anesthetic agent over the others. Mechanisms of neuroprotection by anesthetic agents appear to involve suppression of excitatory neurotransmission, and potentiation of inhibitory activity, which may contribute to the reduction of excitotoxic injury. Activation of intracellular signaling cascades that lead to altered expression of protective genes may also be involved. SUMMARY: Solid experimental evidence supports neuroprotection by anesthetic agents. It is too early to recommend any specific agent for clinical use as a neuroprotectant, however. Further study is warranted to unravel relevant mechanisms and to appreciate the potential clinical relevance of experimental findings.

AB - PURPOSE OF REVIEW: Patients at risk for perioperative stroke, or those who have suffered recent cerebral injury, may benefit from neuroprotective properties of anesthetic agents during surgery. This manuscript reviews recent clinical and experimental evidence for neuroprotective effects of common anesthetic agents, and presents potential mechanisms involved in anesthetic neuroprotection. RECENT FINDINGS: Although strong experimental data support a neuroprotective potential of several anesthetic agents, specifically isoflurane and xenon, consistent long-term protection by either agent has not been demonstrated. Unfortunately, there is a lack of clinical studies that would support the use of any one anesthetic agent over the others. Mechanisms of neuroprotection by anesthetic agents appear to involve suppression of excitatory neurotransmission, and potentiation of inhibitory activity, which may contribute to the reduction of excitotoxic injury. Activation of intracellular signaling cascades that lead to altered expression of protective genes may also be involved. SUMMARY: Solid experimental evidence supports neuroprotection by anesthetic agents. It is too early to recommend any specific agent for clinical use as a neuroprotectant, however. Further study is warranted to unravel relevant mechanisms and to appreciate the potential clinical relevance of experimental findings.

KW - Anesthesia

KW - Neuroprotection

KW - Neurotoxicity

KW - Perioperative cerebral ischemia

KW - Posttreatment

KW - Preconditioning

UR - http://www.scopus.com/inward/record.url?scp=33748669435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748669435&partnerID=8YFLogxK

U2 - 10.1097/01.aco.0000245271.84539.4c

DO - 10.1097/01.aco.0000245271.84539.4c

M3 - Article

C2 - 16960478

AN - SCOPUS:33748669435

VL - 19

SP - 481

EP - 486

JO - Current Opinion in Anaesthesiology

JF - Current Opinion in Anaesthesiology

SN - 0952-7907

IS - 5

ER -